The glass packaging manufacturer serving the cosmetics and pharmaceutical sectors is making steady progress in its sustainability journey. At Paris Packaging Week on February 05-06, SGD Pharma showcased new glass bottles made from 20% and 30% PCR content.
Produced at SGD Pharma’s Zhanjiang facility in China, the solution uses post-consumer recycled (PCR) glass to reduce virgin raw material use and energy consumption. In 2025, the plant has become the first glass manufacturing facility in China to obtain ISO 14021 certification for its PCR glass packaging, marking a significant step forward in the production of verified PCR glass for the cosmetics and beauty sector.
Other advancements in sustainable glass packaging solutions, include the Nova lightweight glass range and the Eclipse refillable glass jar:
- Combining technical precision with sustainability, the Nova bottle achieves up to 20% CO₂ reduction compared with standard models, demonstrating how optimized glass distribution and weight reduction can preserve both structural integrity and visual appeal.
- The Eclipse refillable glass jar was designed to encourage reuse and reduces single-use waste. Its enables consumers to effortlessly replace capsules, extending the life of the outer glass container and supporting circular economy principles in beauty packaging.
SGD Pharma has once again been awarded the EcoVadis Platinum Medal, achieving an outstanding score of 90. This distinction reaffirms the glassmaker’s position as a global leader in sustainable performance within the glass industry.
Building on its Science Based Targets initiative (SBTi)-validated roadmap, SGD Pharma is on track to achieve a 42% reduction in carbon emissions by 2030 and 65% by 2040, compared to 2022 levels.
